US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Carlsmed, Inc.

13.05

+0.28002.19%

Volume:193.89K

Turnover:2.49M

Market Cap:347.04M

PE:-13.18

High:13.06

Open:12.47

Low:12.33

Close:12.77

52wk High:17.19

52wk Low:10.65

Shares:26.59M

Float Shares:6.70M

Volume Ratio:2.53

T/O Rate:2.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9900

EPS(LYR):-6.1108

ROE:--

ROA:--

PB:3.25

PE(LYR):-2.14

Loading ...

Overview Company News Filings

Carlsmed Inc expected to post a loss of 43 cents a share - Earnings Preview

Carlsmed to Present at Canaccord Genuity Musculoskeletal Conference

Carlsmed Announces First corra Cervical Plating Procedure

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

Goldman Sachs Reaffirms Their Buy Rating on Carlsmed, Inc. (CARL)

Carlsmed sees Q4 revenue $15.2M, up 61% year-over-year

Carlsmed Reports 86% Revenue Growth for Full Year 2025

Carlsmed Inc - Full Year 2025 Revenue About $50.5 Mln, up 86% From 2024

THOMSON REUTERS

Carlsmed price target raised to $20 from $19 at Goldman Sachs

Carlsmed Study Shows Personalized Spine Implants Cut Revision Surgeries by 74%

Carlsmed Inc. to Present at J.P. Morgan Healthcare Conference

Carlsmed Price Target Maintained With a $24.00/Share by BTIG

Carlsmed Launches aprevo Technology Platform for Cervical Fusion Surgeries in U.S

Carlsmed Inc. to Present at Piper Sandler Healthcare Conference

Carlsmed, Inc. (CARL) Gets a Buy from Goldman Sachs

Carlsmed Is Maintained at Buy by BTIG

Carlsmed Reports Strong Q3 Growth and Raises Guidance

Carlsmed Q3 EPS $(0.40), Inline, Sales $13.074M Beat $11.398M Estimate

Carlsmed revenue rises 98% to $13.1 million in third quarter 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CARL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CARL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CARL\",,,,,undefined,":{"symbol":"CARL","market":"US","secType":"STK","nameCN":"Carlsmed, Inc.","latestPrice":13.05,"timestamp":1771880400000,"preClose":12.77,"halted":0,"volume":193887,"delay":0,"changeRate":0.02192638997650753,"floatShares":6700000,"shares":26592908,"eps":-0.99,"marketStatus":"Pre-Mkt","change":0.28,"latestTime":"02-24 04:36:40 EST","open":12.47,"high":13.06,"low":12.33,"amount":2487037.2786,"amplitude":0.057165,"askPrice":14.68,"askSize":100,"bidPrice":9.88,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.99,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"listingDate":1753243200000,"exchange":"NASDAQ","adjPreClose":13.05,"postHourTrading":{"tag":"盘后","latestPrice":13.05,"preClose":13.05,"latestTime":"16:10 EST","volume":306,"amount":3993.3,"timestamp":1771881004548,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.530270486611912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CARL\",,,,,undefined,":{"symbol":"CARL","floatShares":6700000,"roa":"--","roe":"--","lyrEps":-6.110816,"volumeRatio":2.530270486611912,"shares":26592908,"dividePrice":0,"high":13.06,"amplitude":0.057165,"preClose":12.77,"low":12.33,"week52Low":10.65,"pbRate":"3.25","psRate":"7.75","week52High":17.19,"institutionHeld":0,"latestPrice":13.05,"eps":-0.99,"divideRate":0,"volume":193887,"delay":0,"ttmEps":-0.99,"open":12.47,"prevYearClose":12.35,"prevWeekClose":12.77,"prevMonthClose":12.42,"prevQuarterClose":12.35,"fiveDayClose":10.95,"twentyDayClose":13.23,"sixtyDayClose":13.89,"earningDate":1771948800000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CARL\",params:#limit:5,,,undefined,":[{"date":"2026-02-25","symbol":"CARL","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-0.43,"defaultRemindTime":1772053200000,"name":null,"time":"Post Market","dateTimestamp":1771995600000,"actualEps":null},{"market":"US","date":"2026-01-12","symbol":"CARL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CARL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CARL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1756616400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CARL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CARL","date":"2026-02-23","current":-13.181818,"percent":0.702703,"low":-17.546462,"twenty":-14.937761,"median":-13.917829,"eighty":-12.980347,"high":-11.112415,"avg":-13.949327,"sd":1.197232,"marketCap":339478663},"quantilePoints":[{"date":"2025-07-25","current":-15.614335,"twenty":-16.208652,"median":-15.938508,"eighty":-15.646752,"marketCap":383160159},{"date":"2025-08-01","current":-15.19291,"twenty":-15.955797,"median":-15.668364,"eighty":-15.646752,"marketCap":372818812},{"date":"2025-08-08","current":-13.129008,"twenty":-15.715909,"median":-15.64135,"eighty":-13.714681,"marketCap":322172729},{"date":"2025-08-15","current":-15.074046,"twenty":-15.668364,"median":-15.074046,"eighty":-13.919991,"marketCap":369902022},{"date":"2025-08-22","current":-13.917829,"twenty":-15.668364,"median":-14.685038,"eighty":-13.671458,"marketCap":341529609},{"date":"2025-08-29","current":-14.793096,"twenty":-15.668364,"median":-14.793096,"eighty":-13.848672,"marketCap":363007791},{"date":"2025-09-05","current":-13.711141,"twenty":-15.646752,"median":-14.674233,"eighty":-13.75266,"marketCap":343162439},{"date":"2025-09-12","current":-14.592647,"twenty":-15.566789,"median":-14.406788,"eighty":-13.75266,"marketCap":365224781},{"date":"2025-09-19","current":-16.302557,"twenty":-15.668364,"median":-14.674233,"eighty":-13.825678,"marketCap":408020406},{"date":"2025-09-26","current":-14.07224,"twenty":-15.668364,"median":-14.74447,"eighty":-13.965375,"marketCap":352200025},{"date":"2025-10-03","current":-14.157205,"twenty":-15.646752,"median":-14.592647,"eighty":-14.050912,"marketCap":354326516},{"date":"2025-10-10","current":-14.518304,"twenty":-15.592248,"median":-14.555476,"eighty":-14.050912,"marketCap":363364101},{"date":"2025-10-17","current":-14.475821,"twenty":-15.533659,"median":-14.518304,"eighty":-13.981553,"marketCap":362300856},{"date":"2025-10-24","current":-13.817347,"twenty":-15.457207,"median":-14.518304,"eighty":-13.981553,"marketCap":345820553},{"date":"2025-10-31","current":-13.49873,"twenty":-15.391314,"median":-14.475821,"eighty":-13.934173,"marketCap":337846213},{"date":"2025-11-07","current":-12.278065,"twenty":-15.357328,"median":-14.412098,"eighty":-13.768492,"marketCap":316049683},{"date":"2025-11-14","current":-13.136609,"twenty":-15.308473,"median":-14.369616,"eighty":-13.698396,"marketCap":338149459},{"date":"2025-11-21","current":-12.207132,"twenty":-15.257494,"median":-14.300582,"eighty":-13.511475,"marketCap":314223790},{"date":"2025-11-28","current":-16.813207,"twenty":-15.273006,"median":-14.317078,"eighty":-13.505102,"marketCap":432788773},{"date":"2025-12-05","current":-14.881961,"twenty":-15.395562,"median":-14.369616,"eighty":-13.53235,"marketCap":383076549},{"date":"2025-12-12","current":-13.560038,"twenty":-15.367948,"median":-14.317078,"eighty":-13.390798,"marketCap":349048931},{"date":"2025-12-19","current":-12.971369,"twenty":-15.31697,"median":-14.284651,"eighty":-13.242594,"marketCap":333896007},{"date":"2025-12-26","current":-14.262309,"twenty":-15.282984,"median":-14.262309,"eighty":-13.270867,"marketCap":367126103},{"date":"2026-01-02","current":-12.754491,"twenty":-15.243074,"median":-14.220928,"eighty":-13.263026,"marketCap":328313350},{"date":"2026-01-09","current":-13.291522,"twenty":-15.222027,"median":-14.158119,"eighty":-13.135089,"marketCap":342137070},{"date":"2026-01-16","current":-13.983466,"twenty":-15.19818,"median":-14.157205,"eighty":-13.135089,"marketCap":359948402},{"date":"2026-01-23","current":-13.683968,"twenty":-15.121592,"median":-14.125343,"eighty":-13.128209,"marketCap":352239020},{"date":"2026-01-30","current":-13.084972,"twenty":-15.046472,"median":-14.099058,"eighty":-13.128209,"marketCap":336820255},{"date":"2026-02-06","current":-11.659773,"twenty":-15.023246,"median":-14.036693,"eighty":-13.091493,"marketCap":300134229},{"date":"2026-02-13","current":-11.112415,"twenty":-14.993,"median":-13.939483,"eighty":-13.018875,"marketCap":286044668},{"date":"2026-02-20","current":-12.919731,"twenty":-14.95017,"median":-13.926001,"eighty":-12.979672,"marketCap":332566803},{"date":"2026-02-23","current":-13.188247,"twenty":-14.937761,"median":-13.917829,"eighty":-12.980347,"marketCap":339478663}],"updateTime":1771925800943},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CARL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613756277","title":"Carlsmed Inc  expected to post a loss of 43 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2613756277","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613756277?lang=en_us&edition=fundamental","pubTime":"2026-02-24 08:02","pubTimestamp":1771891333,"startTime":"0","endTime":"0","summary":"Carlsmed Inc  expected to post a loss of43cents a share - Earnings Preview Carlsmed Inc CARL.OQ CARL.O is expected to  report resultson February 26 for the period ending December 31 2025The Carlsbad C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL8N3ZK003:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2613737585","title":"Carlsmed to Present at Canaccord Genuity Musculoskeletal Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613737585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613737585?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:01","pubTimestamp":1771880491,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL4ZgMZ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4588","SG9999014005.SGD","BK4082","LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","BK4112","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","BK4585","SG9999014039.USD","LU2095319765.USD","CARL"],"gpt_icon":0},{"id":"2612242608","title":"Carlsmed Announces First corra Cervical Plating Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2612242608","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612242608?lang=en_us&edition=fundamental","pubTime":"2026-02-19 05:05","pubTimestamp":1771448729,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. announced the first personalized cervical plating procedure using its corra Cervical Plating System. The procedure was performed by Dr. Aaron Clark at the University of California San Francisco, and marks the start of a clinical evaluation ahead of the company’s planned commercial launch of the corra system later this year. Carlsmed said data from the evaluation will be used for continued product refinement, with additional evaluations expected in the coming months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire  on February 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL3nF1kr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4585","CARL","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","BK4588","SG9999014005.SGD","SG9999014013.SGD","BK4112","SG9999014039.USD","LU0314104364.USD","IE00B64PRP62.GBP","BK4082","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2610218964","title":"Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610218964","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610218964?lang=en_us&edition=fundamental","pubTime":"2026-02-12 05:01","pubTimestamp":1770843660,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Feb.  11, 2026  (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will re","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/11/3236642/0/en/Carlsmed-Inc-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-25-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL","BK4082"],"gpt_icon":0},{"id":"2610625267","title":"Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2610625267","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610625267?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:00","pubTimestamp":1770732000,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Feb.  10, 2026  (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine surgery","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/10/3235384/0/en/Carlsmed-Announces-First-aprevo-Bi-lateral-Posterior-Lumbar-Interbody-Fusion-Procedure.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL","BK4082"],"gpt_icon":0},{"id":"2604915518","title":"Goldman Sachs Reaffirms Their Buy Rating on Carlsmed, Inc. (CARL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604915518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604915518?lang=en_us&edition=fundamental","pubTime":"2026-01-17 02:56","pubTimestamp":1768589784,"startTime":"0","endTime":"0","summary":"In a report released today, David Roman from Goldman Sachs maintained a Buy rating on Carlsmed, Inc., with a price target of $18.00. According to T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-carlsmed-inc-carl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-carlsmed-inc-carl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CARL"],"gpt_icon":0},{"id":"2602510029","title":"Carlsmed sees Q4 revenue $15.2M, up 61% year-over-year","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510029","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510029?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:16","pubTimestamp":1768223765,"startTime":"0","endTime":"0","summary":"Fourth quarter 2025 revenue was approximately $15.2 million, an approximate 61% increase compared to the fourth quarter 2024. Full year 2025 revenu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/carlsmed-sees-q4-revenue-15-2m-up-61-year-over-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/carlsmed-sees-q4-revenue-15-2m-up-61-year-over-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CARL"],"gpt_icon":0},{"id":"2602510957","title":"Carlsmed Reports 86% Revenue Growth for Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510957","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510957?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223115,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. announced preliminary and unaudited revenue results for the fourth quarter and full year ended December 31, 2025. The company reported fourth quarter 2025 revenue of approximately $15.2 million, representing a 61% increase compared to the fourth quarter of 2024. Full year 2025 revenue was approximately $50.5 million, an 86% increase over the full year 2024. The company also noted the addition of 101 new surgeon users in 2025, marking a 61% increase in its total surgeon user base compared to the prior year. These preliminary results are subject to revision until the company files its full financial results for 2025 in its Annual Report on Form 10-K.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL70T8Nl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","CARL","LU0314104364.USD","BK4588","NDAQ","LU2095319765.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4082","BK4585","SG9999014039.USD","SG9999014005.SGD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2602177510","title":"Carlsmed Inc - Full Year 2025 Revenue About $50.5 Mln, up 86% From 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2602177510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602177510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA3SCX4G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CARL","BK4082"],"gpt_icon":0},{"id":"2602227793","title":"Carlsmed price target raised to $20 from $19 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2602227793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602227793?lang=en_us&edition=fundamental","pubTime":"2026-01-09 18:50","pubTimestamp":1767955827,"startTime":"0","endTime":"0","summary":"Goldman Sachs raised the firm’s price target on Carlsmed (CARL) to $20 from $19 and keeps a Buy rating on the shares. After a year when fundamental...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/carlsmed-price-target-raised-to-20-from-19-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/carlsmed-price-target-raised-to-20-from-19-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CARL"],"gpt_icon":0},{"id":"2601848701","title":"Carlsmed Study Shows Personalized Spine Implants Cut Revision Surgeries by 74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601848701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601848701?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:05","pubTimestamp":1767733513,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. has announced the publication of a new retrospective cohort study in the Global Spine Journal evaluating the impact of 3D preoperative planning combined with patient-specific, anatomically designed interbody implants in complex adult spinal deformity  surgery. The study compared 2-year revision rates among ASD patients treated with Carlsmed’s aprevo personalized interbody implants to those receiving conventional stock implants. Results showed that patients who received aprevo implants had a significantly lower revision rate due to mechanical complications  compared to those treated with stock devices , representing a 74% relative reduction . These findings have already been published.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or lega","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL4pzJfs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD","IE00B64PRP62.GBP","CARL","BK4588","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014013.SGD","BK4585","BK4082","LU2210149790.SGD","NDAQ","SG9999014039.USD","BK4112"],"gpt_icon":0},{"id":"2592937639","title":"Carlsmed Inc. to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2592937639","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592937639?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:01","pubTimestamp":1765918868,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. will be participating in the J.P. Morgan 2026 Healthcare Conference, with Chairman and CEO Mike Cordonnier scheduled to present on Wednesday, January 14th, from 4:30 to 5:10 pm PT in San Francisco, CA. The Carlsmed management team will also host one-on-one investor meetings during the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire  on December 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL13hfgb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014013.SGD","LU2210149790.SGD","BK4585","SG9999014039.USD","IE00BGHQF748.EUR","BK4112","IE00BKPKM429.USD","CARL","SG9999014005.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","LU0314104364.USD","NDAQ","LU2095319765.USD","BK4588","BK4082"],"gpt_icon":0},{"id":"2591645921","title":"Carlsmed Price Target Maintained With a $24.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2591645921","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591645921?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:02","pubTimestamp":1765800120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CARL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 15, 2025 07:02 ET (12:02 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL"],"gpt_icon":0},{"id":"2588434240","title":"Carlsmed Launches aprevo Technology Platform for Cervical Fusion Surgeries in U.S","url":"https://stock-news.laohu8.com/highlight/detail?id=2588434240","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588434240?lang=en_us&edition=fundamental","pubTime":"2025-12-03 20:00","pubTimestamp":1764763211,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. has announced the U.S. commercial launch of its aprevo Technology Platform for cervical fusion surgeries, marking a significant expansion of its personalized spine surgery offerings. Building on the success of its lumbar platform, the new cervical system integrates AI-driven preoperative planning with 3D-printed, patient-specific implants tailored to individual anatomy and pathology. Early clinical experience from over 50 cases highlights enhanced implant fit, improved alignment, and efficient workflow integration. The launch was highlighted at the Cervical Spine Research Society  53rd Annual Meeting, with leading surgeons presenting initial clinical data and feedback.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL8rkYPm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4082","LU2210149790.SGD","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","CARL","NDAQ","IE00B64PRP62.GBP","BK4588"],"gpt_icon":0},{"id":"2584297581","title":"Carlsmed Inc. to Present at Piper Sandler Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584297581","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584297581?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:01","pubTimestamp":1763586070,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. will present at the 37th Annual Piper Sandler Healthcare Conference on December 3rd in New York, NY. Chairman and CEO Mike Cordonnier is scheduled to speak, and Carlsmed management will also host one-on-one investor meetings. A live webcast and replay will be available to registered participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire  on November 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL4jF9TK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210150020.SGD","BK4112","LU2095319765.USD","BK4082","IE00B3QW5Z07.USD","NDAQ","BK4585","IE00BGHQF748.EUR","BK4588","CARL","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2584998466","title":"Carlsmed, Inc. (CARL) Gets a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2584998466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584998466?lang=en_us&edition=fundamental","pubTime":"2025-11-18 15:45","pubTimestamp":1763451909,"startTime":"0","endTime":"0","summary":"In a report released yesterday, David Roman from Goldman Sachs reiterated a Buy rating on Carlsmed, Inc., with a price target of $19.00. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/carlsmed-inc-carl-gets-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/carlsmed-inc-carl-gets-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0345770993.USD","LU1868837136.USD","LU0251131958.USD","LU2750360641.GBP","LU2237443622.USD","LU2471134523.USD","IE0004086264.USD","IE0004091025.USD","BK4127","IE00BFXG1179.USD","LU0345770308.USD","LU1894683348.USD","CARL","LU1868837300.USD","LU2237438978.USD","IE00BSNM7G36.USD","LU2237443465.HKD","LU2265009873.SGD","IE0002270589.USD","LU2471134796.USD","IE00B19Z3B42.SGD","LU0048573561.USD","LU1868836591.USD","LU2237443382.USD","LU1868836914.USD","LU2237443549.SGD","LU0742534661.SGD","BK4082","BK4516","LU1791807156.HKD","LU1804176565.USD","LU0106831901.USD","LU2471134879.HKD","BK4585","LU1668664300.SGD","LU1868836757.USD","IE00B19Z3581.USD","IE0034235188.USD","LU2237443978.SGD","LU2471134952.CNY","LU0096364046.USD","LU0251142724.SGD","LU0061475181.USD","BK4552","BK4588","LU1894683264.USD","LU2237443895.HKD","LU2750360997.AUD","BK4550","BK4504"],"gpt_icon":0},{"id":"2581381003","title":"Carlsmed Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2581381003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581381003?lang=en_us&edition=fundamental","pubTime":"2025-11-07 17:39","pubTimestamp":1762508340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CARL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 07, 2025 04:39 ET (09:39 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL"],"gpt_icon":0},{"id":"2581014078","title":"Carlsmed Reports Strong Q3 Growth and Raises Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581014078","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581014078?lang=en_us&edition=fundamental","pubTime":"2025-11-07 14:06","pubTimestamp":1762495589,"startTime":"0","endTime":"0","summary":"Carlsmed, Inc. ( ($CARL) ) has released its Q3 earnings. Here is a breakdown of the information Carlsmed, Inc. presented to its investors. Carlsmed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/carlsmed-reports-strong-q3-growth-and-raises-guidance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/carlsmed-reports-strong-q3-growth-and-raises-guidance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2581012488","title":"Carlsmed Q3 EPS $(0.40), Inline, Sales $13.074M Beat $11.398M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581012488","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581012488?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:01","pubTimestamp":1762462914,"startTime":"0","endTime":"0","summary":"Carlsmed (NASDAQ:CARL) reported quarterly losses of $(0.40) per share which met the analyst consensus estimate. This is a 80.58 percent increase over losses of $(2.06) per share from the same period last year.  The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48702905/carlsmed-q3-eps-0-40-inline-sales-13-074m-beat-11-398m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Carlsmed Q3 EPS $(0.40), Inline, Sales $13.074M Beat $11.398M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL"],"gpt_icon":0},{"id":"2581918017","title":"Carlsmed revenue rises 98% to $13.1 million in third quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581918017","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581918017?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:01","pubTimestamp":1762462899,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. reported third quarter 2025 revenue of $13.1 million, a 98% increase from $6.6 million in the same period last year. Gross profit reached $9.9 million with a gross margin of 75.9%, compared to $4.8 million and 72.8% in the third quarter of 2024. Operating expenses rose to $19.0 million from $12.6 million, with research and development expenses at $4.4 million and sales and marketing expenses at $9.6 million. The company raised its full-year 2025 revenue guidance to $49 million-$50 million. Recent business developments include a reduction in lead time for aprevo interbody implants to eight business days and securing NTAP reimbursement for cervical procedures, with more than 50 patients treated in a clinical evaluation. Carlsmed plans to launch its cervical spine platform early next year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLcb8wDd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","CARL","LU0314104364.USD","BK4588","NDAQ","LU2095319765.USD","IE00BKPKM429.USD","BK4082","BK4585","LU2210150020.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}